Moreover, the Kaplan–Meier survival curve analysis and log-rank test showed a significant difference in survival curve in COVID-19 patients categorized by pulmonary disease, age, IgM, CD16 + /CD56 + NK cells and AST (see Additional file 4: Fig. S4a–e). This evidence concerns the gene NCAM1 and COVID-19.